Gland Pharma

Stocks to watch: Glenmark, Tata Steel, Hero MotoCorp, Zee Entertainment, Tech Mahindra and more

SBI Cards and Indus Towers will release their quarterly results on Thursday, October 27. Sony India and Zee Ent plan to sell three Hindi channels in order to combat anti-competitive behaviour.

Market Opening: Gland Pharma makes market debut, Tata Chemicals continues upward climb

Gland Pharma stocks debut at Rs 1,710, up 15.2% at NSE

Gland Pharma IPO: Issue subscribed 60 percent and QIB fully booked on final day

Gland Pharma IPO: 0.18 % subscription in the first day of bidding

Earlier, the company secured an exemption for its shares from SEBI. Gland Pharma’s 3.87 shares were locked by Enforcement Directorate (ED) for a period of one year. The lock-in of shares was imposed by ED in the Satyam Computers fraud case.

Gland pharma raises Rs 1944 crore ahead of IPO from 70 investors

By allotting 12,959,089 shares to the investors, the company has raised funds at the higher end of the price band at the rate of Rs 1,500 per share 

SEBI exempts lock-in after Satyam Scandal, Gland Pharma to release IPO on November 9

The lock-in of shares was imposed by ED in the Satyam Computers fraud case.

Gland Pharma all set to release biggest pharma IPO in India

Also, Citigroup, Haitong Securities, Kotak Mahindra Bank and Nomura Holdings are managing the deal.